Patent · US Active

Amylin family peptides

US8114958B2 · kind B2 · utility

23Cited by
21References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2005
Grant dateFeb 14, 2012
Priority date
Expiry dateJul 13, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to obesity related polypeptides (ORPs), related nucleic acids, expression constructs, host cells, and processes production of the obesity related polypeptides. The ORPs of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent metabolic disorders such as obesity, diabetes, and increased cardiovascular risk.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.